1. Home
  2. GDRX vs REPL Comparison

GDRX vs REPL Comparison

Compare GDRX & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$2.19

Market Cap

868.9M

Sector

Technology

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$7.93

Market Cap

781.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDRX
REPL
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
868.9M
781.3M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
GDRX
REPL
Price
$2.19
$7.93
Analyst Decision
Buy
Buy
Analyst Count
10
9
Target Price
$4.78
$11.13
AVG Volume (30 Days)
3.5M
1.3M
Earning Date
02-25-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$800,651,000.00
N/A
Revenue This Year
$2.35
N/A
Revenue Next Year
$2.53
N/A
P/E Ratio
$25.20
N/A
Revenue Growth
1.30
N/A
52 Week Low
$2.10
$2.68
52 Week High
$5.81
$14.80

Technical Indicators

Market Signals
Indicator
GDRX
REPL
Relative Strength Index (RSI) 39.88 54.23
Support Level $2.14 $7.43
Resistance Level $2.43 $7.93
Average True Range (ATR) 0.19 0.43
MACD -0.00 0.16
Stochastic Oscillator 21.37 93.53

Price Performance

Historical Comparison
GDRX
REPL

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: